Meeting
2016 ASCO Annual Meeting
Phase II study of chemoselection with docetaxel plus 5-fluorouracil and cisplatin induction chemotherapy and subsequent conversion surgery for locally advanced unresectable esophageal cancer.
Authors
Tomoya Yokota
Shizuoka Cancer Center, Sunto-Gun, Japan
Tomoya Yokota , Ken Kato , Yasuo Hamamoto , Yasuhiro Tsubosa , Hirofumi Ogawa , Yoshinori Ito , Hiroki Hara , Takashi Ura , Takashi Kojima , Keisho Chin , Shuichi Hironaka , Takayuki Kii , Yasushi Kojima , Yasunori Akutsu , Hisayuki Matsushita , Kentaro Kawakami , Keita Mori , Yushi Nagai , Chika Asami , Yuko Kitagawa
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Esophageal or Gastric Cancer
Clinical Trial Registration Number
000011089
Citation
J Clin Oncol 34, 2016 (suppl; abstr 4021)
DOI
10.1200/JCO.2016.34.15_suppl.4021
Abstract #
4021
Poster Bd #
13
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Induction chemotherapy with nanosomal docetaxel lipid suspension (NDLS), cisplatin, and fluorouracil in patients with locally advanced head and neck squamous cell carcinoma.
First Author: Ghanashyam Biswas
Poster
2019 ASCO Annual Meeting
Induction chemotherapy with docetaxel, cisplatin and cetuximab versus docetaxel, cisplatin and 5-fluorouracil followed by radiotherapy with cetuximab for locally advanced or inoperable squamous cell carcinoma of the head and neck: Promising results of a randomized phase II AGMT-trial.
First Author: Felix Keil
Poster
2015 Gastrointestinal Cancers Symposium
Paclitaxel, carboplatin, and capecitabine (TCX) with and without radiation in locally advanced and metastatic distal esophageal and esophagogastric junction cancer: A single-center retrospective review.
First Author: Peter Joel Hosein
Poster
2013 ASCO Annual Meeting
A phase II trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer (KDOG 0501-P2).
First Author: Katsuhiko Higuchi